Venus Remedies (VENUSREM)
FAST GROWERFairStock Score: 54/100 — MIXED
Score breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹999.55 |
| Market Cap | ₹898.8 Cr |
| P/E Ratio | 11.78 |
| ROCE | 11.06% |
| ROE | 14.29% |
| Dividend Yield | 0% |
| Profit Growth | 102.53% |
| Debt/Equity | 0.02 |
| Sales Growth | 2.12% |
| Promoter Holding | 41.76% |
| 52-Week Range | ₹416 — ₹1,800.8 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹368.74 |
Venus Remedies trades with a P/E ratio of 11.78, ROCE of 11.06%, ROE of 14.29%, profit growth of 102.53%, debt-to-equity of 0.02. The FairStock Score of 54/100 suggests mixed fundamentals — some metrics look solid while others need improvement.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer